Skip to main content
Clinical Trials/ACTRN12622001338752
ACTRN12622001338752
Not yet recruiting
未知

The effectiveness of airway clearance in bronchiectasis: A prospective cohort study and review of the patient experience

The University of Sydney0 sites86 target enrollmentOctober 18, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Bronchiectasis
Sponsor
The University of Sydney
Enrollment
86
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Provide their informed consent to participate.
  • 2\)Male or Female above 18 years of age (inclusive) at screening.
  • 3\)Bronchiectasis diagnosed by a treating physician.

Exclusion Criteria

  • 1\)Current smokers as defined by the Centre of Disease C ontrol.
  • 2\)Inability to follow the procedures of the study (e.g. due to barriers of language or cognition)
  • 3\)Cardiothoracic surgery within 6 weeks prior to enrolment
  • 4\)Subjects who have had adjustments to their baseline medications within 1 month prior to screening
  • 5\)Subjects who started on macrolides within 12 months of enrolment.
  • 6\)Subjects taking antibiotics for an acute exacerbation at the time of enrolment.
  • 7\)Severe concomitant illness that may prevent optimal participation in the study
  • 8\)A direct relative of the investigation team
  • 9\)Women who are pregnant
  • 10\)Participation in another clinical trial for bronchiectasis

Outcomes

Primary Outcomes

Not specified

Similar Trials